Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting of fluorouracil, leucovorin, and gemcitabine in treating patients with recurrent or metastatic colorectal cancer.

Key facts

Study ID

NCT00003001

Run by

Stony Brook University

People needed

63

Starts

1997-04-01

Last updated by the study team

2008-07-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• State University of New York Health Sciences Center - Stony Brook — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.